Furthermore, these medications appear to decrease oxidative stress within renal tissues
Semaglutide is the active ingredient in two medications you may have heard of: Ozempic and Wegovy, both made by the pharmaceutical company, Novo Nordisk
These lipid improvements translate to reduced calculated cardiovascular risk scores and potentially lower long-term cardiovascular event rates
If oral medications suit your lifestyle better, PlexusDx Oral Tirzepatide ($349/mo) and Oral Semaglutide ($289/mo) deliver comparable appetite suppression, though absorption is more variable and requires careful timing on an empty stomach
Yet, positive progress made towards combating obesity is at risk due to an impending deadline imposed by the Food and Drug Administration (FDA) that could limit access to compounded GLP-1 medications, raising concerns about the future of obesity management
We should not expect dramatic physical changes